|
|
|
|
New Market Research Report: Auxilium Pharmaceuticals, Inc. - SWOT Analysis
Datamonitor's Auxilium Pharmaceuticals, Inc.- SWOT Analysis company profile is the essential source for top-level company data and information. Auxilium Pharmaceuticals, Inc. - SWOT Analysis examines the company's key business structure and operations,...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care Conference
To listen to the audio web cast of the presentation during or after the event, please visit: http://www.auxilium.com.The replay will be available for ninety days after the event. About Auxilium Auxilium Pharmaceuticals, Inc. is a specialty...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care Conference
MALVERN, PA -- (MARKET WIRE) -- 03/04/10 -- Auxilium Pharmaceuticals, Inc.(NASDAQ: AUXL) today announced that executive management will participate in the Cowen and Co. 30th Annual Health Care Conference to be held March 8 - 11, 2010 at The Boston Marriott...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care Conference
Email a Friend Latest News Releases SOURCE: Auxilium Pharmaceuticals, Inc.MALVERN, PA--(Marketwire - March 4, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ To listen to the audio web cast of the presentation during or after the event, please visit: http:/...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care Conference
Companies mentioned in this article: Auxilium Pharmaceuticals, Inc.MALVERN, PA -- (Marketwire) -- 03/04/10 -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Cowen and Co. 30th Annual Health...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care Conference
MALVERN, PA -- (Marketwire) -- 03/04/10 -- Auxilium Pharmaceuticals, Inc.(NASDAQ: AUXL) today announced that executive management will participate in the Cowen and Co. 30th Annual Health Care Conference to be held March 8 - 11, 2010 at The Boston Marriott...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care Conference
MALVERN, PA -- (Marketwire) -- 03/04/10 -- Auxilium Pharmaceuticals, Inc.(NASDAQ: AUXL) today announced that executive management will participate in the Cowen and Co. 30th Annual Health Care Conference to be held March 8 - 11, 2010 at The Boston Marriott...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care Conference
MALVERN, PA--(Marketwire - 03/04/10) - Auxilium Pharmaceuticals, Inc.(NASDAQ:AUXL - News) today announced that executive management will participate in the Cowen and Co. 30th Annual Health Care Conference to be held March 8 - 11, 2010 at The Boston...
|
|
|
Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th
Auxilium Pharmaceuticals, Inc.(NASDAQ: AUXL) today announced that executive management will participate in the Cowen and Co. 30th Annual Health Care Conference to be held March 8 - 11, 2010 at The Boston Marriott Copley Place. Jim Fickenscher, Chief...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of ...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of ...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
- CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the...
|
|
|
CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%
CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of ...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
Companies mentioned in this article: CPEX Pharmaceuticals, Inc.EXETER, N.H. -- (BUSINESS WIRE) -- CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
EXETER, N.H.- (Business Wire) CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
EXETER, N.H.--(BUSINESS WIRE)-- CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the...
|
|
|
CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results
(BUSINESS WIRE) ----CPEX Pharmaceuticals, Inc.(NASDAQ: CPEX) today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX...
|
|
|
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results, Guidance for 2010 and Selling Price ..
Auxilium Pharmaceuticals, Inc.Announces Fourth Quarter and Full Year 2009 Financial Results, Guidance for 2010 and Selling Price for XIAFLEX Full Year 2009 Net Revenues Increase by 30.8% to a Record $164.0 Million; 2010 Testim(R) Revenues Expected to Be in...
|
|
|
Auxilium Pharma 4Q Loss Narrows On Testim Sales
MALVERN, Pa.-- Biotechnology company Auxilium Pharmaceuticals Inc. said Wednesday its fourth-quarter loss narrowed slightly as higher sales of the hormonal condition drug Testim outweighed a boost in costs. The company lost $11.9 million, or 25...
|
|
|
CPEX Pharmaceuticals Announces Arcadia Opportunity Master Fund Withdraws Previously Stated Intention to Submit Shareholder Proposals and Nominate Director Slate at 2010 Annual Meeting
Arcadia Retains Intent to Nominate One Director EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals Inc.(NASDAQ: CPEX - News) today announced it has received notice from Arcadia Opportunity Master Fund, Ltd. that it has withdrawn its intention, as stated...
|
|
|
Auxilium Pharma 4Q Loss Narrows on Testim Sales
Biotechnology company Auxilium Pharmaceuticals Inc.said Wednesday its fourth-quarter loss narrowed slightly as higher sales of the hormonal condition drug Testim outweighed a boost in costs. The company lost $11.9 million, or 25 cents per share,...
|
|
|
Auxilium Pharma 4Q loss narrows on Testim sales (AP)
MALVERN, Pa.Biotechnology company Auxilium Pharmaceuticals Inc. said Wednesday its fourth-quarter loss narrowed slightly as higher sales of the hormonal condition drug Testim outweighed a boost in costs. The company lost $11.9 million, or 25 cents...
|
|
|
Auxilium Pharma 4Q loss narrows on Testim sales
MALVERN, Pa.(AP) - Biotechnology company Auxilium Pharmaceuticals Inc. said Wednesday its fourth-quarter loss narrowed slightly as higher sales of the hormonal condition drug Testim outweighed a boost in costs. The company lost $11.9 million, or 25...
|
